Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
Without research studies on the use in the second and third trimester, we dont know if use of GLP-1s could increase the chances of other pregnancy-related problems
By integrating recent studies, we provided an overview of GLP-1RAs in liver pathology and their prospects in clinical practice
If you are currently taking semaglutide or tirzepatide, speak with your doctor about a safe transition plan
Retrieved July 27, 2026 from www.sciencedaily.com
Effect of glycaemic control itself on preventing CKD is relatively small, compared with multifactorial therapy in patients with diabetes [7, 8]